| Basics |
Boston Scientific Corp.
Boston Scientific Corp is a developer, manufacturer, and marketer of medical devices. The firm markets its devices to health-care professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
|
| IPO Date: |
January 3, 1994 |
| Sector: |
Healthcare |
| Industry: |
Health Care Equipment and Supplies |
| Market Cap: |
$148.96B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.32 | 1.22%
|
| Avg Daily Range (30 D): |
$0.95 | 0.95%
|
| Avg Daily Range (90 D): |
$0.88 | 0.86%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
9.91M |
| Avg Daily Volume (30 D): |
8.95M |
| Avg Daily Volume (90 D): |
6.59M |
| Trade Size |
| Avg Trade Size (Sh.): |
255 |
| Avg Trade Size (Sh.) (30 D): |
73 |
| Avg Trade Size (Sh.) (90 D): |
70 |
| Institutional Trades |
| Total Inst.Trades: |
103,116 |
| Avg Inst. Trade: |
$3.2M |
| Avg Inst. Trade (30 D): |
$9.39M |
| Avg Inst. Trade (90 D): |
$10.88M |
| Avg Inst. Trade Volume: |
.11M |
| Avg Inst. Trades (Per Day): |
18 |
| Market Closing Trades |
| Avg Closing Trade: |
$26.18M |
| Avg Closing Trade (30 D): |
$141.36M |
| Avg Closing Trade (90 D): |
$127.15M |
| Avg Closing Volume: |
688.48K |
|
|
| Financials |
| |
TTM |
Q2 2025 |
Q1 2025 |
|
Basic EPS
|
$1.69
|
$.54
|
$.46
|
|
Diluted EPS
|
$1.68
|
$.53
|
$.45
|
|
Revenue
|
$ 18.49B
|
$ 5.06B
|
$ 4.66B
|
|
Gross Profit
|
$ 12.63B
|
$ 3.42B
|
$ 3.21B
|
|
Net Income / Loss
|
$ 2.5B
|
$ 795M
|
$ 672M
|
|
Operating Income / Loss
|
$ 3.15B
|
$ 819M
|
$ 921M
|
|
Cost of Revenue
|
$ 5.87B
|
$ 1.64B
|
$ 1.45B
|
|
Net Cash Flow
|
$ -2320M
|
$ -178M
|
$ 313M
|
|
PE Ratio
|
62.11
|
|
|
|
|
|
